Single agent gemcitabine (gem) in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Hugec, V [1 ]
Koulova, L [1 ]
Garino, A [1 ]
Wiernik, PH [1 ]
Dutcher, JP [1 ]
机构：
[1] Our Lady Mercy Med Ctr, Bronx, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：452S / 452S
页数：1
相关论文
共 50 条
  • [1] Combination of gemcitabine and doxorubicin in sarcomatoid and/or rapidly progressive metastatic renal cell carcinoma (MRCC)
    Roubaud, G.
    Dilhuydy, M. S.
    Pasticier, G.
    de Clermont, H.
    Smith, D.
    Rayaud, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 308 - 309
  • [2] Burden of cancer in metastatic renal cell carcinoma (mRCC).
    Battle, Dena
    Griffith, Meghan
    Msaouel, Pavlos
    Psutka, Sarah P.
    Vaishampayan, Ulka N.
    Zhang, Tian
    Staehler, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [3] SUNITINIB (SU) RECHALLENGE IN METASTATIC RENAL CELL CARCINOMA (MRCC): A SINGLE INSTITUTION EXPERIENCE
    Febbraro, Antonio
    Giordano, Guido
    ANTICANCER RESEARCH, 2014, 34 (05) : 2626 - 2627
  • [4] Metastatic renal cell carcinoma (MRCC): Responses to different immunotherapies
    Landonio, G
    Baiocchi, C
    Ferrari, M
    Gottardi, O
    Majno, M
    Scanzi, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 468 - 468
  • [5] Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC).
    Luo, Jia
    Podolak, Jennifer
    Degnin, Catherine
    Chen, Yiyi
    Robinson, Kyle William
    Pukay, Marina
    Schilling, Amy
    Poage, Cara
    Thomas, George V.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine
    Fujiwara, Yoshiro
    Kiura, Katsuyuki
    Tabata, Masahiro
    Takigawa, Nagio
    Hotta, Katsuyuki
    Umemura, Shigeki
    Omori, Masako
    Gemba, Kenichi
    Ueoka, Hiroshi
    Tanimoto, Mitsune
    ANTI-CANCER DRUGS, 2008, 19 (04) : 431 - 433
  • [7] Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)
    Spees, Lisa P.
    Greiner, Melissa A.
    Dinan, Michaela A.
    Wilson, Lauren E.
    Pritchard, Jessica E.
    Zhang, Tian
    Kaye, Deborah
    George, Daniel
    Scales, Charles D.
    Baggett, Chris D.
    Gross, Cary P.
    Leapman, Michael S.
    Wheeler, Stephanie B.
    UROLOGY, 2022, 168 : 129 - 136
  • [8] Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).
    Dinan, Michaela Ann
    Wilson, Lauren E.
    Greiner, Melissa A.
    Spees, Lisa
    Pritchard, Jessica
    Zhang Tian
    Kaye, Deborah
    George, Daniel J.
    Scales, Charles D.
    Wheeler, Stephanie B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Complications of pazopanib in metastatic renal cell carcinoma (mRCC) in a single tertiary centre: a case series
    Alagappan, K.
    Nasuha, N. A.
    BJU INTERNATIONAL, 2019, 123 : 8 - 8
  • [10] Australian Treatment Practices for Patients with Metastatic Renal Cell Carcinoma (MRCC)
    Liow, Elizabeth
    Baenziger, Olivia
    Corrente, Claudia
    Law, Nicholas
    Azad, Arun
    Shapiro, Julia
    Shapiro, Jeremy
    Weickhardt, Andrew
    Schmidt, Andrew
    Parnis, Francis
    Wong, Shirley
    Parente, Phillip
    Anton, Angelyn
    Pezaro, Carmel
    Tran, Ben
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 55 - 55
12345